Wire by Fusion42
Fusion42 Scout Raise
The Debrief & Outliers
Regulatory RadarWorkday Debrief · Mon 09:00 UTCSector Deep DiveWorkday Debrief · Tue 09:00 UTCGeo PulseWorkday Debrief · Wed 09:00 UTCOperating ConditionsWorkday Debrief · Thu 09:00 UTCWeekly BriefingWorkday Debrief · Fri 09:00 UTCWTF Happened This WeekSat 09:00 UTC · 3σ outliers
Benchmarks
Benchmarks HomeBy News TypeBy RegionBy Sector
AI WeeklyAbout

Switch product

Fusion42RaiseScoutWire

The Debrief & Outliers

All editionsRegulatory RadarWorkday Debrief · Mon 09:00 UTCSector Deep DiveWorkday Debrief · Tue 09:00 UTCGeo PulseWorkday Debrief · Wed 09:00 UTCOperating ConditionsWorkday Debrief · Thu 09:00 UTCWeekly BriefingWorkday Debrief · Fri 09:00 UTCWTF Happened This WeekSat 09:00 UTC · 3σ outliers

Database & benchmarks

Benchmarks HomeBy News TypeBy RegionBy SectorStories

Account

Sign in
← Back

Wire · opportunities

Decentralized Clinical Trial Technology Platform Market Revenue Cross $6.11 Billion By ...

7 September 2026 · By · Wire by Fusion42

Published

7 September 2026

Topic

opportunities

◆ Sectors

Digital Health

◆ Geography

United Kingdom

◆ Source

Read at einpresswire.com →

◆ Verified

Fusion42 · 7 September 2026 · Fusion42 review

The decentralized clinical trial technology platform market is rapidly growing, projected to reach $6.12 billion by 2030 due to rising telemedicine adoption, patient-centric trial models, and digital innovation in remote clinical research.

This Wire brief sits within Fusion42's coverage of Digital Health.

◆ ◆ The Wire takeaway

Digital Health founders building tools for clinical trials have a growing opportunity to integrate telemedicine and patient-focused features now as hybrid and remote trials become standard practice.

◆ Coverage

1 source · 7 Sep 2026

◆ Related on Wire

◆ Topics

Digital Healthdigital-healthclinical-trialstelemedicineremote-monitoringpatient-centric